DEFINITIVE PROXY STATEMENT

Company

ABVC BIOPHARMA, INC.

Filed

March 5, 2026

Period of Report

March 26, 2026

Accession Number

0001213900-26-024122

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →